Influenza A viruses (IAVs) cause substantial morbidity and mortality in yearly epidemics, which result from the ability of the virus to alter the antigenicity of its envelope proteins. Despite the rapid replication of this virus and its ability to infect a wide variety of cell types, viremia is rare and the infection is generally limited to the upper respiratory tract. The preimmune host defense response against IAV is generally, therefore, successful. We have previously provided (and summa-
Introduction
The product of influenza A virus (IAV)' hemagglutinin (HA) genes is expressed on the surface of infected cells and evokes specific and long-lived humoral and cell-mediated immune re-A preliminary report of some of the data presented in this paper has been published in abstract form ( 1991. J. Cell Biol. 115:361 a.) sponses (1) . However, frequent mutations occur in HA genes such that antigenic determinants of the virus are altered, rendering previously immune individuals susceptible to repeat infection (2) . These changes result in frequent epidemics and, occasionally, pandemics of influenza. Although considerable morbidity and mortality may be associated with these outbreaks, there is heterogeneity in the clinical outcome for different individuals infected with the same viral strain (3) . For half a century it has been recognized that serum factors can inhibit influenza hemagglutination (4) . Recently, it has been established that one class of serum HA inhibitors, the "beta" inhibitors, are mannose-binding lectins (4, 5) . Several strains ofIAV that have been selected on the basis of resistance to growth inhibition by beta inhibitors have been characterized (4, 5) . In each case a specific mutation has been found in the resistant strain (as compared with the parent, sensitive, strain), that leads to loss of a specific glycosylation site. For two of the strains, the parent virus is known to have at this site a high mannose glycan attachment that lies in close proximity to the cell attachment site ofthe HA. These findings suggest that beta inhibitors of IAV act by binding to these high mannose structures, thus masking the cell attachment domain of the HA.
Two candidate serum lectins that may constitute beta inhibitors are mannose-binding protein (MBP) and conglutinin (5) (6) (7) . MBP and conglutinin are members ofa family of mammalian serum lectins that have in common a Ca2+-dependent lectin-binding domain at the COOH terminus and a collagenous domain followed by a short area of disulfide bonds at the NH2 terminus (6) . Both are present as multimeric structures in serum. Structurally both resemble C I q and are able to bind to Clq receptors through their collagen domain (6, 7) .
This study has focused on the interaction of recombinant MBPs with several strains of IAV. MBPs have been characterized in the serum ofmice, rats, rabbits, and humans (6, 7) . The physiological role for these proteins appears to be in first line host defense and they may be considered as pattern-recognition molecules that function as ante-antibodies (8) . MBPs are acute-phase reactants (9, 10) that recognize a wide variety of disparate oligosaccharides that are present on the cell walls of certain Gram-negative bacteria ( 1), fungal pathogens ( 12), and the envelope glycoprotein of human immunodeficiency virus ( 13 ) . There are at least two allelic variants ofMBP. In the vast majority of individuals there is one aberration in the collagen region at the eighth repeat as Gly-Gln-Gly is present rather than Gly-X-Y-Gly. In 5-7% ofthe population Asp replaces Gly at the fifth collagen repeat, in addition to the irregularity observed more commonly ( 14) . Homozygosity for this latter phenotype appears to segregate with low serum MBP levels, which in turn have been associated with the phenotype of recurrent infections (14, 15) . However, in recent studies both allelic forms of MBP have been shown to have similar functional properties in vitro. One important difference is that the recombinant MBP containing the Gly to Asp mutation at the fifth collagen repeat was not able to fix complement via the classical pathway ( 14) . In this paper we assess the interaction of both forms of MBP with various influenza viral strains selected for known differences in HA glycosylation.
MBP-ligand complexes would be expected to encounter circulating cells, in particular neutrophils, which have been shown to ingest bacteria opsonized with MBP ( 11) . Neutrophils alone may play a role in the preimmune host defense against influenza ( 16, 17) . We and others have characterized the interaction of human neutrophils with unopsonized IAV and found evidence that these cells are activated by IAV. In the absence of antibody, neutrophils are stimulated by cell-free virus to generate a pertussis toxin-insensitive respiratory burst response, characterized by hydrogen peroxide (H202), but no superoxide (O°-) production ( 18, 19) . Neutrophils are also reported to specifically adhere to IAV-infected epithelial monolayers without mediation of antibody (20) . After exposure to influenza viruses in vitro and in vivo, however, neutrophils and monocytes exhibit depressed responsiveness to various stimuli and depressed microbicidal activity against bacteria (21, 22) .
In this report we demonstrate that both forms of recombinant MBP inhibit IAV HA activity and act as opsonins, enhancing neutrophil responsiveness to the virus.
Methods
Reagents. FMLP, cytochalasin B, horseradish peroxidase type II, scopoletin, SOD, cytochrome c, neuraminidase type X (protease activity < 0.002 U/mg protein), ficol, dextran, sodium citrate, citric acid, and nitroblue tetrazolium were purchased from Sigma Chemical Co. MBPpreparation. Recombinant MBPG (rMBPG) and rMBPD were prepared from cDNAs differing only at base pair 230. These cDNAs were subcloned in a eukaryotic expression vector transfected into murine Sp2 cells and MBPs were purified from the supernatants by calcium-dependent binding to mannan-Sepharose and EDTA elution or by binding to an affinity matrix of anti-MBP monoclonal antibody coupled to Affigel (Bio-Rad Laboratories, Richmond, CA) as previously described ( 14) . MBPs were dialyzed in PBS and stored at -70°C in aliquots. The specific activities were measured by comparison with a standard preparation using mannan-coated ELISA plates as described ( 14) .
Virus preparation. Virus stocks were grown in the chorioallantoic fluid of 10-d-old embryonated hen's eggs and purified on a discontinuous sucrose density gradient as previously described (21 Virus plaque formation was assessed on Madin-Darby canine kidney cells: duplicate confluent monolayers in six-well plates were exposed to virus preparations with or without MBP in 10-fold dilutions in serum-free CRCM-30 medium (Sigma Chemical Co.) for 1 h at 370C, followed by washing twice in PBS. The monolayers were then overlaid with CRCM-30 media with 0.1% BSA, 0.4% agarose, 10 ,ug/ml trypsin, and 10 ;g/ml DEAE-Dextran. The agarose solution was warmed until melting and allowed to cool to the touch, and then mixed with the other ingredients and layered over the cells before solidification. The monolayers were then kept at 370C in a 5% CO2 incubator for 72 h, followed by removal ofthe agarose overlay. After staining with crystal violet, the plaques were counted by direct inspection and titers ofplaque-forming units (PFU)/ml calculated. Values given are mean PFU/ml for two wells. MDCK cells were obtained from the American Type Culture Collection (Rockville, MD).
Neutrophils from healthy volunteer donors were isolated to > 95% purity as previously described using dextran precipitation, followed by a Ficoll-Hypaque gradient separation for removal ofmononuclear cells and hypotonic lysis to eliminate contaminating erythrocytes (21 ) . Cell viability was > 98% as determined by trypan blue staining, and cells were used within 5 h of isolation.
Measurement ofneutrophil activation. H202 production was measured by the oxidation ofscopoletin, and°2-was assessed by the continuous monitoring of the SOD-inhibitable reduction of cytochrome c as previously detailed ( 18 ) . Cell membrane potential was measured using the fluorescent probe bisoxynol as previously detailed ( 18 ) . Neutrophil deactivation was assessed by first incubating cells with IAV (either unopsonized or opsonized with MBP) for various periods of time followed by measurement of°2 production in response to FMLP.
In some of the assays of H202 or°-production, mannan alone or MBP treated with mannan were added before stimulation of the cells with IAV or FMLP. It was, however, observed that mannan alone, at quantities sufficient to inhibit the effects of MBP on viral HA activity, inhibited respiratory burst responses to both stimuli. Final concentrations of 250 or 500 jig/ml of mannan reduced both H202 and°2 responses by 2 30% (n = 3). Concentrations of mannan 2 500 gg/ml also inhibited the measured°2 produced by xanthine oxidase in a dose-related manner. The inhibitory effects of mannan on neutrophil respiratory burst responses was, therefore, at least in part attributable to direct interference with°2 detection. As detailed below, mannan did not interfere with neutrophil membrane depolarization responses, so this assay was used to assess the ability of mannan to alter the effects of MBP on neutrophil activation responses to IAV.
Results
Effect ofMBP on IA V infectivity and hemagglutination titers The IAV strains used in these experiments were selected to assess the role of high mannose oligosaccharide attachments to the viral HA in mediating MBP-IAV interactions. In Table I To examine whether rMBPG could inhibit viral infectivity we also tested the effects of preincubation with rMBPG on plaque titers of IAV. Aliquots of highly concentrated IAV were preincubated with the lectin exactly as described in fig. 1 . For the Texas 77 strain, preincubation of a preparation containing 2 x 109 PFU/ml with 70 ,ug/ml rMBPG caused a one-log reduction in PFU titer (i.e., to a mean PFU titer of 1.5 X 108; n = 2 experiments). When a starting PFU titer of 2 X 108 was used, 35 ,ug/ml of rMBPG caused a two-log reduction. A log reduction of PFU titer of concentrated Mem7 lH-BelN resulted from preincubation with 35 ,ug/ml rMBPG whereas no, or minimal, inhibition of PFU titers ofthe glycosylation mutant were seen in three experiments (data not shown). These results show that MBP can inhibit infectivity ofH3 IAV strains, probably through binding to high mannose carbohydrate attachments on the viral HA. (Fig. 2) . A representative tracing of scopoletin fluorescence decrease (indicative of H202 production) in response to MBP-opsonized IAV is given in Fig. 2 B. Note that preincubation of the virus with the lectin was necessary to achieve enhancement. When MBP alone was added to neutrophils, followed by addition of IAV, no significant enhancement was seen (Fig. 2 B) . Preincubation of neutrophils with MBP alone similarly did not enhance H202 responses to FMLP (data not shown), indicating that the lectin did not have a general priming effect on neutrophil responses. Also note that neither H202 nor°2-production was induced by MBP alone (Fig. 2 B and data not shown).
Neutrophil membrane depolarization. IAV-induces neutro-
phil membrane depolarization in a time course similar to the induction of H202 production ( 18, 19) . Preincubation of IAV with MBP significantly enhanced this response. Texas 77 IAV opsonized with 2.2 Ag/ ml rMBPG increased the rate of neutrophil membrane depolarization (as measured by changes in bisoxynol fluorescence) from 7±1 for virus alone to 15±3 for MBP-opsonized virus. These results are mean±SEM change in arbitrary fluorescence units (n = 4; P < 0.03 for IAV alone vs. MBP-opsonized IAV). When MBP was preincubated with mannan (10 mg/ml) before addition of virus, the enhancing effect of MBP was lost: mean±SEM depolarization rate of 7±2 for IAV incubated with MBP and mannan. In contrast to its effects on respiratory burst assays, mannan alone (at the same concentration) did not significantly alter the membrane depolarization response to IAV (mean±SEM depolarization rate was 7±2 for mannan plus IAV) nor did it alter the depolarization response to FMLP (data not shown).
MBP protects neutrophils from the deactivating effects ofIA V
In addition to causing neutrophil activation, influenza A viruses also suppress respiratory burst and other responses ofthe infected neutrophil to subsequent stimulation by a wide range of agonists (21, 22 (Fig. 2) . Note also that neither IAV nor MBP-opsonized IAV caused superoxide production in their own right. This is in accord with our previous findings using IAV ( 18, 19) . It is unlikely, therefore, that the ability of MBP to protect neutrophils from the deactivating effects of IAV is a direct result of its ability to enhance respiratory burst responses to the virus itself.
Effects of rMBPD on IA V and on the IA V-neutrophil interaction Human serum MBP exists in two allelic forms that differ as a result of a single base pair change at base pair 230 that results in a Gly to Asp substitution. The latter form is less prevalent and is referred to as rMBPD. It has been suggested ( 15) that this allelic form may be associated with susceptibility to infection. We therefore performed experiments to determine whether rMBPD differed from rMBPG in its interaction with IAV or neutrophils.
rMBPD had similar effects to rMBPG on IAV HA titers, inhibiting HA activity of the Texas 77 and Mem7IH-BelN strains of IAV while having no significant effect against the Mem7lH-BelN/BS mutant strain. Fig. 3 depicts the dose-response relationship for HA inhibition of the Texas 77 strain of IAV resulting from preincubation with rMBPD. Note that inclusion of 5 mM EGTA during the incubation ofthe virus with rMBPD substantially inhibited the effects of the lectin on viral HA activity. Preincubation of concentrated Mem7lH-BelN IAV (2,000 HAU/ml) with 250, 66, and 33 jig/ml of rMBPD caused, respectively, 90±10, 70+10, and 50±0% (mean of two determinations) reductions in the HA titers whereas 100 tg/ ml of rMBPD had no effect on HA titers of 2,000 HAU of the Mem7 lH-BelN/BS strain. Inhibition of infectivity of Texas 77 was also found with rMBPD (PFU reduced from 7 X 101 to 6 X I0 PFU.ml by preincubation with 88 ,ug/ml rMBPD).
As was the case with rMBPG, significant enhancement of IAV-induced neutrophil H202 production was also observed when Texas 77 or Mem7lH-BelN IAV were opsonized with rMBPD. As shown in Fig. 4 , significantly enhanced H202 responses were obtained with Texas 77 IAV opsonized with 1.1, 2.75, or 5.5 ,tg/ml of this MBP preparation. For Mem71H-BelN, opsonization with 3.3 ,g/ml of rMBPD increased H202 production from 0.98 ± 0.18 to 2.7 ± 0.11 nmol/min per 4 -a E -Texas 77 -----Texas 77 + EGTA Figure 3 . Effects of preincubation of concentrated Texas 77 IAV with rMBPD on HA titers. Experiments were performed as described in Fig. 1 . These results represent mean±SEM of three experiments. Where error bars are not shown identical results were obtained in replicate experiments. Where indicated, 5 mM EGTA was included during the incubation of MBP with IAV (mean±SEM of two experiments). All MBP-treated samples (except those where EGTA was used) had significantly (P < 0.05) reduced HAU titers compared with untreated virus. 1418 Hartshorn, Sastry, White, Anders, Super, Ezekowitz, and Tauber   0  100  200  300  400  500 rMBPD Concentration(ug/mi) X 10O6 cells (n = 3; P < 0.02). In parallel experiments no effect of rMBPD was found on H202 responses to the glycosylation mutant Mem7lH-BelN/BS (control response 1.04±0.19 vs. 0.42±0.04 for MBP-treated samples). (Responses were higher in the experiments involving the effects of rMBPD on H202 production elicited by the Mem7 1 strains than in earlier experiments due to use of cytochalasin-B before virus).
As described above for rMBPG, opsonization with rMBPD enhanced neutrophil membrane depolarization responses to Texas 77 IAV, an effect again inhibited by preincubation ofthe MBP with mannan (see Fig. 5 ).
Preincubation of Texas 77 IAV with rMBPD also significantly inhibited neutrophil deactivation caused by this virus strain. The O2 response to FMLP was 77±3% of control when neutrophils were preincubated with 100 HAU/ml of Texas 77 IAV and 97±3% of control when neutrophils were pretreated with this amount of virus opsonized with a 1.1 sg/ml concentration of rMBPD (n = 4; P < 0.03). It thus appears that both forms of MBP have comparable functional activity as determined by these assay systems.
Discussion
In this report we demonstrate that two allelic variants ofrecombinant MBP inhibit HA activity of several H3 strains of IAV. Binding to a specific high mannose attachment present near the sialic acid-binding pocket of the HA of H3 IAV strains is crucial to these effects, as demonstrated using the glycosylation mutant of Mem7 lH-BelN IAV. Opsonization of IAV with both forms of MBP also enhances neutrophil respiratory burst and membrane depolarization responses to cell-free IAV. Of further interest, the MBPs appear to protect neutrophils from the deactivating effects of IAV. This protective effect occurs at somewhat higher concentrations of MBP than are necessary to provide significant enhancement of the respiratory burst. Protection from deactivation requires substantial inhibition of viral HA activity. This finding is similar to results we have obtained using antibodies that neutralize IAV HA activity (unpublished data) and supports the concept that viral HA bind- ing to neutrophil surface sialic acid residues is critical for causing deactivation. This corroborates the finding ofCassidy et al. (25) that purified IAV HA preparations can mediate deactivation. It is of further interest that, in the setting where deactivation and HA activity are strongly inhibited by MBP, the opsonized virus still activates more vigorous neutrophil respiratory burst responses than unopsonized controls. Whether MBP-opsonized IAV activates neutrophils in a qualitatively different manner than the unopsonized virus requires further study. Activation by MBP-opsonized IAV is similar to that triggered by the unopsonized virus in that only H202, without accompanying superoxide, is produced. We have studied this phenomenon extensively with respect to unopsonized IAV ( 18, 19, 26) . Our findings indicate that the lack of superoxide production may be accounted for by postulating that the virus-induced respiratory burst occurs largely at an intracellular site from which H202, but not O°, can diffuse out to the extra-cellular space and be detected ( 19) . This may also be the case for the burst elicited by MBP-opsonized IAV, although this has yet to be proven.
We have conducted experiments with MBP isolated from human serum (gift ofDr. Jens Jensenius, University ofAarhus, Aarhus, Denmark) and found HA inhibition, enhancement of neutrophil respiratory burst responses, and inhibition of IAVinduced neutrophil deactivation with this preparation as well (data not shown). We have also observed similar effects using bovine conglutinin (Hartshorn, (6, 7) . Both molecules also have the ability to bind to the cellular Clq receptor via their highly conserved collagen domains (27) . Recent studies indicate that conglutinin may be the major constituent of the bovine serum beta inhibitor of IAV infectivity whereas another lectin, possibly MBP, plays this role in murine serum (5) . The finding that these lectins also favorably alter neutrophil interactions with IAV adds an important new dimension to our understanding of their potential role in ante-antibody immunity to this virus. It may be that the related lectins found in pulmonary surfactant (6) have similar effects vis-a-vis IAV as well. These surfactant lectins may be particularly well positioned to contribute to the initial defense against IAV in the lung.
The various effects of rMBPG in our experiments were observed at concentrations of the lectin normally present in human serum ( 14) . All ofthe observed effects would be expected to influence favorably the outcome of IAV infection in vivo, either through direct antiviral effects of the lectin or through enhancing neutrophil antimicrobial mechanisms and protecting the neutrophil from virus-induced dysfunction. The effective concentrations of rMBPG and rMBPD appear to be very similar from our data. In experiments using the two preparations of MBP to opsonize bacteria ( 14) , major differences in ability to bind to or opsonize bacteria were not found. It appears likely, therefore, that the ability to opsonize organisms is not dramatically different between the two allelic variants of MBP. However, MBPG was able to fix complement via the classical pathway, whereas rMBPD was not, despite the fact that both recombinant preparations were capable of forming hexamers (i.e., C Iq-like configurations). The precise role of mannose-binding protein in IAV infection in vivo remains to be determined. One intriguing possibility that one can conclude from our in vitro studies is that absent or dysfunctional MBP may contribute to bacterial superinfection as a result ofneutrophil deactivation. In this regard it would be interesting to identify patients who had bacterial superinfection after IAV infection and to determine the concentrations of MBP in their serum and respiratory secretions.
Further studies are still required on how mannose-binding proteins alter IAV binding, uptake into and survival in phagocytes. The relative contribution of putative IAV and MBP receptors on the neutrophil to activation needs to be established. Addition ofcomplement to the MBP-opsonized virus model is likely to result in more potent neutrophil activation and viral killing. Studies ofthe interaction ofMBP (or conglutinin) with other respiratory viral strains may reveal expanded clinical relevance of the lectins in preimmune antiviral responses. Specifically, H 1 IAV isolates other than PR-8 may interact with MBP. The WSN strain has more mannose residues on its HA than PR-8 (28) , and more recently isolated H1 strains (since the reintroduction of this subtype into active circulation in the human population in 1976) have acquired changes in oligosaccharide attachments as compared with PR-8 (29) and are sensitive to beta-inhibitors (5). The effects ofMBP on influenza B and parainfluenza viruses are also of interest. We believe that the results of these various studies will confirm an important role for mammalian C-type lectins, in conjunction with phagocytic cells, in the natural immune response to influenza and perhaps other related virus infections.
